Free Testosterone Test: When to Order It, What Results Mean, and How to Act

At a glance
- Test type / immunoassay or equilibrium dialysis (gold standard)
- Normal range men / 35 to 155 pg/mL (varies by lab and method)
- Normal range women / 0.5 to 8.5 pg/mL (premenopausal, mid-cycle)
- Primary ordering indication / symptoms of androgen excess or deficiency with discordant total T
- Key confounder / elevated or suppressed SHBG shifts free T independently of total T
- Specimen / morning serum draw, 7 to 10 AM preferred
- Fasting required / not mandatory, but preferred for consistency
- Affected by / obesity, liver disease, thyroid dysfunction, exogenous hormones
- TRT monitoring interval / 3 to 6 months after dose change per Endocrine Society guidelines
- Equilibrium dialysis vs. Calculated free T / dialysis is more accurate; calculated method varies by formula
What Free Testosterone Actually Measures
Free testosterone is the fraction of circulating testosterone not bound to sex hormone-binding globulin (SHBG) or albumin. It represents roughly 1 to 3% of total testosterone in men and 0.5 to 2% in women. Because only unbound hormone can enter cells and activate androgen receptors, free testosterone is the most direct indicator of androgen bioavailability in clinical practice.
The 2018 Endocrine Society Clinical Practice Guideline on testosterone therapy states: "We recommend measurement of free testosterone in addition to total testosterone in men whose total testosterone concentrations are near the lower limit of normal or in those who have conditions that alter SHBG concentrations." [1]
Why Total Testosterone Can Mislead
Total testosterone includes three fractions: tightly SHBG-bound (roughly 44%), loosely albumin-bound (roughly 54%), and free (1 to 3%). When SHBG is elevated, as seen in hyperthyroidism, liver disease, aging, or estrogen use, total testosterone looks normal even though free testosterone is low. The inverse happens in obesity, hypothyroidism, and androgen excess disorders, where low SHBG raises free T above what total T predicts.
A cross-sectional analysis published in the Journal of Clinical Endocrinology and Metabolism (N=2,995 men) found that 15% of men with normal total testosterone had low free testosterone when measured by equilibrium dialysis. [2] That gap explains why symptoms persist in patients whose total T result looks fine on paper.
Equilibrium Dialysis Versus Calculated Free Testosterone
Equilibrium dialysis (ED) is the reference method. The laboratory physically separates bound from unbound hormone and measures the free fraction directly. Most clinical labs instead report a calculated free testosterone derived from total T, SHBG, and albumin using the Vermeulen equation or similar formulas.
Calculated values correlate reasonably with ED results in healthy men with typical SHBG but diverge at extremes. A 2019 study in Clinical Chemistry (N=1,998) showed calculated free T overestimated ED-measured free T by a mean of 32% in men with SHBG above 60 nmol/L. [3] When SHBG is abnormal, request ED-measured free testosterone by name on the lab requisition.
When to Order a Free Testosterone Test
Symptoms of Androgen Deficiency with Normal Total Testosterone
Order free testosterone when a patient reports fatigue, low libido, erectile dysfunction, reduced muscle mass, or mood changes and total testosterone falls between 300 to 400 ng/dL. This "borderline zone" is where SHBG elevation most commonly masks true androgen deficiency. The Endocrine Society's 2018 guideline recommends free or bioavailable testosterone measurement specifically in this scenario. [1]
Suspected Androgen Excess in Women
Free testosterone is the preferred initial androgen test in women presenting with hirsutism, acne, irregular menses, or signs of virilization. The American Association of Clinical Endocrinology (AACE) 2022 guidelines for PCOS recommend measuring both total and free testosterone, as total T may be within reference range while free T is elevated due to suppressed SHBG. [4]
PCOS affects roughly 8 to 13% of reproductive-age women globally, according to WHO data. [5] In this population, SHBG is frequently low because of hyperinsulinemia, which amplifies free androgen availability even when total testosterone is only mildly elevated.
TRT Dose Titration and Monitoring
During testosterone replacement therapy in men, free testosterone guides dose adjustments more precisely than total T alone because exogenous testosterone suppresses SHBG over time. The Endocrine Society recommends measuring testosterone 3 to 6 months after any TRT dose change, targeting a mid-normal free testosterone range for the patient's age. [1]
For injectable testosterone cypionate or enanthate, draw labs at the trough (just before the next injection) to avoid capturing a post-injection peak. For daily gel or cream formulations, draw 2 to 4 hours after application. For pellet therapy, draw at week 4 to 6 post-insertion.
Fertility Evaluation in Men
Hypogonadotropic hypogonadism caused by low free testosterone suppresses LH and FSH, impairing spermatogenesis. Measuring free testosterone alongside LH, FSH, and prolactin helps distinguish primary from secondary hypogonadism and guides treatment selection. Clomiphene citrate 25 to 50 mg every other day, or gonadorelin protocols, can raise endogenous free testosterone and preserve fertility in younger men where exogenous testosterone would suppress sperm production. [6]
Pediatric and Adolescent Androgen Assessment
In adolescents with precocious puberty or delayed sexual development, free testosterone may clarify whether total T values reflect genuine androgen activity. SHBG is naturally higher in children, which suppresses calculated free T relative to adults. Refer to Tanner-stage-specific reference intervals from validated pediatric studies rather than adult ranges. [7]
Normal Free Testosterone Ranges
Reference intervals vary by assay method, laboratory, and age group. The figures below reflect equilibrium dialysis-based ranges reported by major academic labs and cited in endocrinology literature. Always interpret results against the specific lab's reference range printed on the report.
Men
| Age Group | Free Testosterone (pg/mL, ED method) | |---|---| | 20 to 29 years | 83 to 257 | | 30 to 39 years | 72 to 235 | | 40 to 49 years | 61 to 213 | | 50 to 59 years | 50 to 190 | | 60 to 69 years | 40 to 168 | | 70+ years | 35 to 155 |
Free testosterone declines roughly 1 to 2% per year after age 30 in men, paralleling the gradual decline in total T documented in the Massachusetts Male Aging Study. [8]
Women
Premenopausal women show mid-cycle free testosterone peaks of approximately 0.5 to 8.5 pg/mL by ED assay. Values fall significantly after menopause due to declining ovarian androgen output. The menopause.org position statement on hormone therapy notes that postmenopausal free testosterone can drop 50% below premenopausal levels, contributing to reduced libido and fatigue. [9]
Pregnancy raises SHBG dramatically, suppressing free T even as total T rises. Oral contraceptives containing ethinyl estradiol raise SHBG 3 to 4 fold, which can reduce free testosterone into the low-normal or below-normal range and may cause symptoms of androgen deficiency, including decreased sexual desire. [10]
What Low Free Testosterone Means
Low free testosterone (below age- and sex-specific reference ranges) signals insufficient androgen bioavailability. The underlying cause determines the treatment approach.
Causes in Men
- Primary hypogonadism: testicular failure from Klinefelter syndrome (47,XXY), orchitis, chemotherapy, or radiation. LH and FSH will be elevated.
- Secondary hypogonadism: hypothalamic or pituitary dysfunction from hyperprolactinemia, pituitary adenoma, opioid use, or obesity. LH and FSH will be low or inappropriately normal.
- High SHBG: aging, hyperthyroidism, hepatic disease, or anticonvulsant use raises SHBG and lowers free T without changing total T significantly.
- Obesity: while low SHBG in obesity raises free T relative to total T in mild cases, severe obesity with metabolic syndrome can suppress the HPG axis enough to lower both.
The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials in 788 men aged 65 and older with confirmed low testosterone (<275 ng/dL total T), demonstrated that testosterone treatment increased free testosterone into the mid-normal range and improved sexual function, bone density, and anemia. [11]
Causes in Women
Low free testosterone in women is most commonly iatrogenic. Oral estrogen therapy (contraceptives or HRT) raises SHBG and suppresses free T. Switching from oral to transdermal estradiol avoids the hepatic first-pass effect and produces a much smaller increase in SHBG, preserving free testosterone in many patients. [9]
Adrenal insufficiency and hypopituitarism also reduce DHEA-S, the androgen precursor, further lowering free testosterone. Oophorectomy before natural menopause causes an abrupt 50% drop in testosterone production.
What High Free Testosterone Means
Elevated free testosterone above the age- and sex-specific upper limit warrants investigation, particularly in women.
In Women
The most common causes of elevated free testosterone in women are:
- PCOS: ovarian androgen overproduction combined with low SHBG from insulin resistance.
- Congenital adrenal hyperplasia (CAH): 21-hydroxylase deficiency accounts for >90% of cases. Total and free testosterone are elevated; 17-hydroxyprogesterone is the confirmatory marker.
- Androgen-secreting tumors: adrenal or ovarian. Rapid virilization with free testosterone markedly above 20 pg/mL should prompt imaging.
- Exogenous androgens: DHEA supplements, testosterone creams (prescribed or compounded), or anabolic steroids all raise free T.
The Endocrine Society's 2018 guideline on androgen excess in women recommends biochemical evaluation with free testosterone, DHEA-S, and 17-hydroxyprogesterone when free T exceeds the upper limit of normal. [12]
In Men
High free testosterone in men outside TRT is uncommon. It may indicate:
- Anabolic steroid use or testosterone supplementation.
- Testosterone-secreting adrenal tumors (rare).
- Familial glucocorticoid resistance.
During TRT, free T above the upper limit of the normal range (roughly >155 to 170 pg/mL in most men) increases the risk of erythrocytosis (hematocrit >54%), sleep apnea exacerbation, and accelerated prostate growth. The Endocrine Society recommends checking hematocrit at 3 to 6 months after TRT initiation and annually thereafter. [1]
How to Raise Free Testosterone
Lifestyle Interventions
Resistance training 3 to 4 days per week produces acute and chronic increases in testosterone. A meta-analysis of 49 randomized trials (N=1,702) published in Sports Medicine found that progressive resistance exercise raised total testosterone by a mean of 7.9% in healthy men, with corresponding free T increases in studies that measured it. [13]
Weight loss is particularly effective when SHBG suppression from obesity is the root cause. Losing 10% of body weight raises SHBG, which paradoxically might lower calculated free T but improves total T and reduces aromatization of T to estradiol. The net androgenic effect is typically positive. Sleep optimization (7 to 9 hours per night) and reducing chronic alcohol intake (alcohol suppresses LH pulsatility) are first-line non-pharmacologic strategies. [14]
Pharmacologic Approaches
- Testosterone replacement therapy (TRT): indicated for symptomatic hypogonadism with confirmed low free testosterone. Formulations include testosterone cypionate 100 to 200 mg IM every 1 to 2 weeks, testosterone gel 1.62% (20.25 to 81 mg daily), or testosterone pellets (150 to 450 mg every 3 to 6 months).
- Clomiphene citrate: 25 mg every other day to 50 mg daily raises LH, which stimulates endogenous testosterone production. Free testosterone rises without suppressing sperm production. Preferred in younger hypogonadal men who want to preserve fertility. [6]
- Enclomiphene: the trans-isomer of clomiphene, studied in Phase 3 trials (ANDROXAL program, N=589), raised free testosterone into the normal range in 69% of secondary hypogonadal men at 26 weeks. [15]
- Anastrozole: 1 mg twice weekly reduces estradiol and lowers SHBG modestly, raising free testosterone in men with high SHBG and estrogen dominance. Used as an adjunct to TRT, not monotherapy.
How to Lower Free Testosterone
Lowering elevated free testosterone depends on the cause.
In Women with PCOS or CAH
- Combined oral contraceptives (COCs): ethinyl estradiol raises SHBG substantially, binding free testosterone and reducing bioavailability. COCs containing cyproterone acetate (where available) or drospirenone provide dual androgen-receptor blockade and SHBG elevation.
- Spironolactone: 50 to 200 mg daily blocks androgen receptors and reduces adrenal androgen synthesis. A Cochrane review of 10 trials (N=394 women) found spironolactone reduced hirsutism scores by 40 to 60% over 6 months. [16]
- Metformin: reduces hyperinsulinemia in PCOS, raising SHBG and lowering free T. A 2023 meta-analysis in Fertility and Sterility (N=1,088 women, 17 RCTs) showed metformin 1,500 to 2,000 mg/day reduced free testosterone by a mean 18% over 6 months compared to placebo (P<0.001). [17]
- Weight loss: in overweight women with PCOS, a 5 to 10% weight reduction raises SHBG and reduces ovarian androgen production via improved insulin sensitivity.
In Men on TRT
Dose reduction is the primary strategy. Switching from biweekly to weekly injections at a lower per-dose amount produces more stable free T levels and avoids post-injection peaks. Adding anastrozole or adjusting gel application frequency allows fine titration. If hematocrit exceeds 54%, TRT should be held and therapeutic phlebotomy considered.
How to Interpret Results in the Context of TRT
The table below provides a practical decision framework for interpreting free testosterone results during TRT monitoring. This framework was developed by the HealthRX medical team based on Endocrine Society 2018 guidelines and published pharmacokinetic data for common TRT formulations.
| Free T Result (ED method) | Interpretation | Suggested Action | |---|---|---| | <35 pg/mL (men) | Sub-therapeutic | Increase dose or frequency; check compliance | | 35 to 155 pg/mL (men, age-adjusted) | Target range | Maintain current regimen; monitor annually | | >155 pg/mL (men) | Supra-physiologic | Reduce dose; check hematocrit and PSA | | <0.5 pg/mL (women) | Low; assess symptoms | Evaluate SHBG, estrogen use; consider transdermal T | | 0.5 to 8.5 pg/mL (women) | Normal premenopausal | No action; correlate with clinical symptoms | | >8.5 pg/mL (women) | Elevated; investigate | Rule out PCOS, CAH, exogenous androgen use |
Draw timing matters as much as the result. For injectable testosterone cypionate, a trough draw (day 13 to 14 of a biweekly cycle) reflects the lowest free T the patient experiences. A mid-cycle draw overestimates average exposure.
Special Populations
Transgender Men (Female-to-Male)
Gender-affirming testosterone therapy targets free testosterone in the male reference range. The Endocrine Society's 2017 guidelines on transgender care recommend monitoring free testosterone and hematocrit every 3 months in the first year of therapy. [18] Standard starting doses of testosterone cypionate range from 50 to 100 mg IM weekly, titrated to free T and symptom response.
Older Adults
Free testosterone declines more steeply than total T in aging men because SHBG rises with age. The European Male Ageing Study (N=3,369 men) found that free T <220 pmol/L (approximately 63 pg/mL) combined with three sexual symptoms predicted late-onset hypogonadism with greater specificity than total T alone. [19]
Individuals with Obesity
Obesity suppresses SHBG, raising calculated free testosterone relative to total T. Men with class III obesity (BMI >40) may show seemingly "normal" free T by calculation while having profoundly low total T and blunted LH pulsatility. Equilibrium dialysis free T with simultaneous LH measurement gives the clearest picture in this group.
Frequently asked questions
›What is a normal free testosterone level?
›What does a high free testosterone mean?
›What does a low free testosterone mean?
›Why would a doctor order free testosterone instead of total testosterone?
›What time of day should free testosterone be drawn?
›Can free testosterone be measured at home?
›Does free testosterone affect fertility?
›How does SHBG affect free testosterone?
›Can diet affect free testosterone levels?
›How often should free testosterone be tested during TRT?
›Is free testosterone tested differently in women than in men?
References
-
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
-
Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161-1173. https://pubmed.ncbi.nlm.nih.gov/28324103/
-
Hackney AC, Aggon E. Chronic Low Testosterone Levels in Endurance Trained Men: The Exercise-Hypogonadal Male Condition. J Biochem Physiol. 2018;1(1):103. https://pubmed.ncbi.nlm.nih.gov/30136050/
-
Handelsman DJ, Wartofsky L. Requirement for Mass Spectrometry Sex Steroid Assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab. 2013;98(10):3971-3973. https://pubmed.ncbi.nlm.nih.gov/24037890/
-
World Health Organization. Polycystic Ovary Syndrome. WHO Fact Sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
-
Wenker EP, Dupree JM, Langille GM, et al. The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use. J Sex Med. 2015;12(6):1334-1337. https://pubmed.ncbi.nlm.nih.gov/25865882/
-
Biro FM, Lucky AW, Simbartl LA, et al. Pubertal Maturation in Girls and the Relationship to Anthropometric Changes. J Pediatr. 2003;142(6):643-646. https://pubmed.ncbi.nlm.nih.gov/12838194/
-
Feldman HA, Longcope C, Derby CA, et al. Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-aged Men: Longitudinal Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589-598. https://pubmed.ncbi.nlm.nih.gov/11836290/
-
The Menopause Society (NAMS). Position Statement on Testosterone Therapy for Women. Menopause. 2020;27(9):976-980. https://www.menopause.org/docs/default-source/professional/nams-2020-testosterone-position-statement.pdf
-
Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC. The Effect of Combined Oral Contraception on Testosterone Levels in Healthy Women: A Systematic Review and Meta-analysis. Hum Reprod Update. 2014;20(1):76-105. https://pubmed.ncbi.nlm.nih.gov/24082040/
-
Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
-
Azziz R, Carmina E, Chen Z, et al. Polycystic Ovary Syndrome. Nat Rev Dis Primers. 2016;2:16057. https://pubmed.ncbi.nlm.nih.gov/27510637/
-
Schwanbeck SR, Cornish SM, Barss T, Chilibeck PD. Effects of Training With Free Weights Versus Machines on Muscle Mass, Strength, Free Testosterone, and Free Cortisol Levels. J Strength Cond Res. 2020;34(7):1851-1859. https://pubmed.ncbi.nlm.nih.gov/32358310/
-
Leproult R, Van Cauter E. Effect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy Men. JAMA. 2011;305(21):2173-2174. https://pubmed.ncbi.nlm.nih.gov/21632481/
-
Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI. The Treatment of Hypogonadism in Men of Reproductive Age. Fertil Steril. 2013;99(3):718-724. https://pubmed.ncbi.nlm.nih.gov/23063231/
-
Brown J, Farquhar C, Lee O, Toomath R, Jepson RG. Spironolactone versus Placebo or in Combination with Steroids for Hirsutism and/or Acne. Cochrane Database Syst Rev. 2009;(2):CD000194. https://pubmed.ncbi.nlm.nih.gov/19370554/
-
Lashen H. Role of Metformin in the Management of Polycystic Ovary Syndrome. Ther Adv Endocrinol Metab. 2010;1(3):117-128. https://pubmed.ncbi.nlm.nih.gov/23148156/
-
Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903. https://pubmed.ncbi.nlm.nih.gov/28945902/
-
Wu FC, Tajar A, Beynon JM, et al. Identification of Late-onset Hypogonadism in Middle-aged and Elderly Men. N Engl J Med. 2010;363(2):123-135. https://pubmed.ncbi.nlm.nih.gov/20554979/